Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
2-N-(4-[4'-N',N'-(dimethylamino)phenylazo]-benzoyl-L-serinyl-L-phenylalanylamido)-N''-ethylaminonaphthalene-5-sulfonic acid + H2O
?
-
-
-
?
carbobenzoxy-L-aspartic acid + L-phenylalanine methyl ester
carbobenzoxy-L-aspartyl-L-phenylalanine methyl ester
condensation, the enzyme is enantioselective for the desired L-phenylalanine methyl ester substrate from a racemic mixture of DL-phenylalanine methyl ester. In contrast, although both enantiomers of carbobenzoxy-L-aspartic acid can bind to the enzyme, only carbobenzoxy-L-aspartic acid is used since carbobenzoxy-D-aspartic acid inhibits the enzyme, substrate carbobenzoxy-L-aspartic acid binding structures, detailed overview
precipitation as the water-insoluble Phe-OMe salt drives the overall reaction in the direction of peptide synthesis
-
?
casein + H2O
?
from bovine milk
-
-
?
casein + H2O
L-tyrosine + ?
from bovine milk
-
-
?
cellular prion protein + H2O
?
thermolysin degrades cellular prion protein while preserving both proteinase K-sensitive and proteinase K-resistant isoforms of disease-related prion protein in both rodent and human prion strains. In variant Creutzfeldt-Jakob disease, up to 90% of total prion protein present in the brain resists degradation with thermolysin, whereas only about 15% of this material resists digestion by proteinase K
-
-
?
N-(3-[2-furyl]acryloyl)-Gly-Leu amide + H2O
?
-
-
-
?
N-carbobenzoxy-L-Asp-L-Phe-methyl ester + H2O
N-carbobenzoxy-L-Asp + L-Phe-methyl ester
-
-
-
?
N-carbobenzoxy-L-aspartyl-L-phenylalanine methyl ester + H2O
?
-
-
-
?
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide + H2O
?
-
-
-
?
N-[3-(2-furyl)acryloyl]-glycyl-L-leucine amide + H2O
?
Tyr-Gly-Gly-Phe-Leu + H2O
?
-
-
?
[3H]Tyr-Gly-Gly-Phe-Leu + H2O
?
-
-
-
?
(7-methoxycoumarin-4-yl) acetyl-L-Pro-L-Leu-Gly-L-Leu-[N3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl]-L-Ala-L-Arg-NH2 + H2O
?
(7-methoxycoumarin-4-yl)acetyl-Arg-Pro-Pro-Gly-Phe-Ser-Ala-Phe-Lys-(2,4-dinitrophenyl)-OH + H2O
?
-
a bradykinin-like substrate
-
-
?
(7-methoxycoumarin-4yl) acetyl-L-Pro-L-Leu-Gly-L-Leu-[N3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-L-Ala-L-Arg-NH2 + H2O
?
-
-
-
-
?
(europium(III) complex of a modified terpyridine)-K1K1K1-GFSAK1K1K-black hole quencher 2 + H2O
?
-
thermolysin cleaves the substrates at the glycine-phenylalanine bond
-
-
?
(europium(III) complex of a modified terpyridine)-K1K2K2GFSAK2K-black hole quencher 2 + H2O
?
-
thermolysin cleaves the substrates at the glycine-phenylalanine bond
-
-
?
(europium(III) complex of a modified terpyridine)-K1K2K2GFSAK2K2K-black hole quencher 2 + H2O
?
-
thermolysin cleaves the substrates at the glycine-phenylalanine bond
-
-
?
1-beta-D-arabinofuranosyl-N4-lauroylcytosine + H2O
?
-
-
-
-
?
11S soy protein + H2O
?
-
-
-
-
?
2-hydroxy-N-(4-methyl-2-nitrophenyl)-3-nitrobenzamide + H2O
?
-
-
-
-
?
3-(2-furylacryloyl)-glycyl-L-leucine amide + H2O
?
-
-
-
?
5-bromo-N-(4-bromophenyl)-2-hydroxy-3-nitro-benzamide + H2O
?
-
-
-
-
?
7S soy protein + H2O
?
-
-
-
-
?
Ac-Gly-Leu-Ala-methylamide + H2O
?
-
model substrate, enzyme-substrate complex, docking structures, overview
-
-
ir
alphaS1-casein + H2O
caseicin A + ?
-
-
antimicrobial peptide product caseicin A = IKHQGLPQE
-
?
azocasein + H2O
?
-
-
-
-
?
benzyloxycarbonyl-(4-nitro)Phe-Leu-Ala + H2O
?
-
-
-
-
?
benzyloxycarbonyl-Asp + Phe-methylester
benzyloxycarbonyl-Asp-Phe methyl ester + H2O
benzyloxycarbonyl-Gly-(4-nitro)Phe-Leu-Ala + H2O
?
-
-
-
-
?
benzyloxycarbonyl-Gly-Gly-(4-nitro)Phe-Leu-Ala + H2O
?
-
-
-
-
?
benzyloxycarbonyl-Gly-Gly-Phe-Leu-Ala + H2O
?
-
-
-
-
?
benzyloxycarbonyl-Gly-Phe-Leu-Ala + H2O
?
-
-
-
-
?
benzyloxycarbonyl-Phe-Leu-Ala + H2O
?
-
-
-
-
?
bovine alpha-lactalbumin + H2O
?
-
reaction at 25°C and 70°C under nonreducing conditions. At 25°C, substrate undergoes limited hydrolysis leading to peptides no longer degraded. At 70°C, protein is first quickly cleaved, then unfolded, leading to the release of intermediate peptides that may be further degraded
-
-
?
bovine beta-lactoglobulin A + H2O
?
-
analysis of 25 peptides released by enzyme at 37°C, comparison with peptides relased at 25°C, 60 and 80°C. Test of peptides for angiotensin-converting enzyme inhibiting activity
-
-
?
Carbobenzoxy-Gly-Pro-Leu-Ala-Pro + H2O
?
-
-
-
-
?
Dansyl peptides + H2O
?
-
-
-
-
?
dansyl-Ala-Ala-Phe-Ala + H2O
?
-
-
-
-
?
dansyl-Ala-Leu-Ala + H2O
?
-
-
-
-
?
dansyl-Ala-Phe-Ala + H2O
?
-
-
-
-
?
dansyl-Gly-Gly-Leu-Gly + H2O
?
-
-
-
-
?
dansyl-Gly-Leu-Gly + H2O
?
-
-
-
-
?
dansyl-Gly-Leu-Phe + H2O
?
-
-
-
-
?
Dansyl-Gly-Phe-Ala + H2O
?
-
-
-
-
?
dansyl-Gly-Phe-Gly + H2O
?
-
-
-
-
?
dansyl-Gly-Phe-Phe + H2O
?
-
-
-
-
?
Elastin + H2O
?
-
from bovine neck ligament
-
-
?
F-Asp-PheOMe + H2O
?
-
dipeptide synthesis
-
r
FA-glycyl-L-leucine amide + H2O
?
-
-
-
?
furylacryloyl-Gly-Leu-NH2 + H2O
furylacryloyl-Gly + Leu-NH2
-
-
-
-
?
GFA + H2O
Phe-Ala + Gly
-
-
-
?
GFSA + H2O
Gly-Phe + Phe-Ser-Ala + Gly + Ser-Ala
-
-
-
?
Gly-Phe-Leu + H2O
Phe-Leu + Gly-Phe + Gly + Leu
-
-
-
?
H-Gly-Phe-Ala-OH + H2O
?
-
-
-
?
H-Gly-Phe-Leu-OH + H2O
?
-
-
-
?
H-Gly-Phe-Ser-Ala-Lys-Asn-Gln-Ser-Asn-Gln-Arg-OH + H2O
?
-
-
-
?
H-Gly-Phe-Ser-Ala-Lys-Asn-Gln-Ser-OH + H2O
?
-
-
-
?
H-Gly-Phe-Ser-OH + H2O
?
-
-
-
?
H-Gly-Ser-Ala-OH + H2O
?
-
-
-
?
leucine enkephalin + H2O
?
Mca-Arg-Pro-Pro-Gly-Phe-Ser-Ala-Phe-Lys(Dnp)-OH + H2O
?
-
-
-
-
?
N'-[3-(2-furyl)acryloyl]glycyl-L-leucinamide + H2O
?
-
-
-
-
?
N,N'-diBoc-dityrosyl-(Ile-isoniazid)2 + H2O
N,N'-diBoc-dityrosyl + 2 Ile-isoniazid
-
-
-
-
?
N,N'-diBoc-dityrosyl-(Phe-isoniazid)2 + H2O
N,N'-diBoc-dityrosyl + 2 Phe-isoniazid
-
-
-
-
?
N-(2,3-dimethylphenyl)-2-hydroxy-3-nitro-benzamide + H2O
?
-
-
-
-
?
N-(2,4-dimethylphenyl)-2-hydroxy-3-nitro-benzamide + H2O
?
-
-
-
-
?
N-(2,5-dimethylphenyl)-2-hydroxy-3-nitrobenzamide + H2O
?
-
-
-
-
?
N-(2-chloro-4-nitrophenyl)-2-hydroxy-3-nitro-benzamide + H2O
?
-
-
-
-
?
N-(2-chloro-6-methylphenyl)-2-hydroxy-3-nitrobenzamide + H2O
?
-
-
-
-
?
N-(2-ethylphenyl)-2-hydroxy-3-nitrobenzamide + H2O
?
-
-
-
-
?
N-(5-chloro-2-methoxyphenyl)-2-hydroxy-3-nitro-benzamide + H2O
?
-
-
-
-
?
N-(Benzyloxycarbonyl)-L-Phe + L-Phe methyl ester
N-(Benzyloxycarbonyl)-L-Phe-L-Phe methyl ester + H2O
N-benzyloxycarbonyl-L-Asp-L-Phe-methyl ester + H2O
N-benzyloxycarbonyl-L-Asp + L-Phe-methyl ester
-
-
-
-
?
N-carbobenzoxy-Gly-L-Leu-NH2 + H2O
?
-
-
-
-
?
N-carbobenzoxy-L-Asp-L-Phe methyl ester + H2O
?
-
-
-
-
?
N-carbobenzoxy-L-Asp-L-Phe-methyl ester + H2O
?
-
-
-
-
?
N-carbobenzoxy-L-Asp-L-Phe-methyl ester + H2O
N-carbobenzoxy-L-Asp + L-Phe-methyl ester
-
-
-
-
?
N-carbobenzoxy-L-Asp-L-Phe-methyl ester + H2O
N-carbobenzoxy-L-aspartic acid + L-phenylalanine methyl ester
-
-
-
-
r
N-carbobenzyloxy-L-Asp-L-Phe methyl ester + H2O
?
-
-
-
-
?
N-carboxybenzoyl-L-aspartyl-L-phenylalanine methyl ester + H2O
?
-
-
-
?
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide + H2O
?
-
-
-
-
?
N-[3-(2-furyl)acryloyl]-Gly-L-Leu-NH2 + H2O
?
N-[3-(2-furyl)acryloyl]-glycyl-L-leucine amide + H2O
?
N-[3-(2-furyl)acryloyl]-glycyl-L-leucine amide + H2O
N-[3-(2-furyl)acryloyl]-glycine + L-leucine amide
-
-
-
-
?
N-[3-(2-furyl)acryloyl]-L-leucine-L-alanine amide + H2O
?
-
i.e. FALAA
-
-
?
N-[3-(2-furyl)acryloyl]-Phe-Ala amide + H2O
?
-
-
-
?
N-[3-(2-furyl)acryloyl]glycyl-L-leucinamide + H2O
?
-
-
-
-
?
Nalpha-benzyloxycarbonyl-L-aspartyl-L-phenylalanine methyl ester + H2O
?
-
-
-
?
oxyquinoline + H2O
?
-
-
-
-
?
Phe-Leu-Ala-NH(CH2)2NH-dansyl + H2O
?
-
-
-
-
?
Pro-urokinase + H2O
?
-
thermolysin activates thrombin-inactivated pro-urokinase nearly as rapidly as it does the native zymogen, cleavage of Arg156-Phe157 and Lys158-Ile159
-
-
?
soy protein isolate + H2O
?
-
-
-
-
?
tryptic hydrolysate of bovine beta casein + H2O
?
-
-
-
-
?
Z-Arg-PheOMe + H2O
?
-
dipeptide synthesis
-
?
[3H]leucine enkephalin + H2O
?
-
-
-
?
additional information
?
-
N-[3-(2-furyl)acryloyl]-glycyl-L-leucine amide + H2O
?
-
-
-
?
N-[3-(2-furyl)acryloyl]-glycyl-L-leucine amide + H2O
?
i.e. FAGLA
-
-
?
(7-methoxycoumarin-4-yl) acetyl-L-Pro-L-Leu-Gly-L-Leu-[N3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl]-L-Ala-L-Arg-NH2 + H2O
?
-
fluorescent substrate
-
?
(7-methoxycoumarin-4-yl) acetyl-L-Pro-L-Leu-Gly-L-Leu-[N3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl]-L-Ala-L-Arg-NH2 + H2O
?
-
i.e. MOCAc-PLGL(Dpa)AR, fluorescent substrate
-
-
?
benzyloxycarbonyl-Asp + Phe-methylester
benzyloxycarbonyl-Asp-Phe methyl ester + H2O
-
-
-
?
benzyloxycarbonyl-Asp + Phe-methylester
benzyloxycarbonyl-Asp-Phe methyl ester + H2O
-
-
-
?
Collagen + H2O
?
-
from bovine achilles tendon
-
-
?
Collagen + H2O
?
-
collagen in solid articular cartilage at 70°C. Overnight digestion with thermolysin completely solubilized cartilage. Following thermolysin treatments, almost all glycosaminoglycans are extracted from the cartilage
-
-
?
GFS + H2O
Gly + Phe-Ser
-
-
-
?
GFS + H2O
Gly + Phe-Ser
-
-
-
?
leucine enkephalin + H2O
?
-
-
-
-
?
leucine enkephalin + H2O
?
-
-
-
?
N-(Benzyloxycarbonyl)-L-Phe + L-Phe methyl ester
N-(Benzyloxycarbonyl)-L-Phe-L-Phe methyl ester + H2O
-
-
-
?
N-(Benzyloxycarbonyl)-L-Phe + L-Phe methyl ester
N-(Benzyloxycarbonyl)-L-Phe-L-Phe methyl ester + H2O
-
-
-
?
N-[3-(2-furyl)acryloyl]-Gly-L-Leu-NH2 + H2O
?
-
-
-
?
N-[3-(2-furyl)acryloyl]-Gly-L-Leu-NH2 + H2O
?
-
-
-
-
?
N-[3-(2-furyl)acryloyl]-glycyl-L-leucine amide + H2O
?
-
-
-
r
N-[3-(2-furyl)acryloyl]-glycyl-L-leucine amide + H2O
?
-
i.e. FAGLA
-
-
?
additional information
?
-
binding of substrates to the active site of thermolysin, overview
-
-
?
additional information
?
-
-
-
-
-
?
additional information
?
-
-
-
-
-
?
additional information
?
-
-
specificity overview: various synthetic peptides
-
-
?
additional information
?
-
-
specificity overview: oligopeptides
-
-
?
additional information
?
-
-
enzyme additionally catalyzes the transesterification of vinyl laurate to several sucrose-containing tri- and tetrasaccharides. Preferred position of acylation is the 2-OH group of the alpha-D-glucopyranose moiety linked 1 to 2 to the beta-D-fructofuranose unit
-
-
?
additional information
?
-
-
enzyme catalyzes the formation of beta-cyclodextrin esters using vinyl esters of butyrate, decanoate and laurate, as acyl donors in dimethylsulfoxide. Esterification occurs exclusively at the glucose C-2 position. Enzyme also catalyzes the synthesis of alpha-, beta-, gamma- and maltosyl-beta-cyclodextrin esters with vinyl laurate as the acyl donor in dimethylsulfoxide and dimethylformamide
-
-
?
additional information
?
-
-
enzyme prefers basic resiudes in P3 position
-
-
?
additional information
?
-
-
digestion of brain homogenates from healthy and scrapie-affected sheep as well as healthy and BSE-affected cattle, the PK digestion results in the amino-terminal truncation of PrPSc-producing PrP species with molecular weights of approx 17, 21, and 27 kDa that can only be detected with antibodies binding to the carboxy-terminal region of PrP, the so-called protease-resistant core or PrP27-30, overview
-
-
?
additional information
?
-
-
thermolysin is a thermostable neutral metalloproteinase and performs autocatalytic cleavage for pro-enzyme activation
-
-
?
additional information
?
-
-
thermolysin performs Co2+-stimulable autolysis
-
-
?
additional information
?
-
-
the major site for thermolysin cleavage specificity, (the S1' site), accepts large hydrophobic residues. Thermolysin preferentially cleaves at the N-terminal side of hydrophobic or bulky amino side chains such as Leu, Phe, Ile and Val. Thermolysin also cleaves bonds of Met, His, Tyr, Ala, Asn, Ser, Thr, Gly, Lys, Glu or Asp at the P1' site
-
-
?
additional information
?
-
-
isolated intact chloroplast from Spinacia oleracea are treated with thermolysin, mass spectrometric analysis and two-dimensional analysis of shedded envelope proteins, including 28 kDa ribonucleoprotein, cytosolic HSP70/Com70, translocon Tic40-like protein, ClpC, HSP70, and hexokinase 1, overview
-
-
?
additional information
?
-
-
synthesis and evaluation of substrates useful for the selective and sensitive assay of thermolysin, overview
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
2-(acetyloxy)-3-chlorobenzoic acid
-
2-ethyl-3-hydroxyquinazolin-4(3H)-one
-
3-hydroxy-2-isopropylquinazolin-4(3H)-one
-
3-hydroxy-2-methylquinazolin-4(3H)-one
-
carbobenzoxy-D-aspartic acid
-
carbobenzoxy-L-aspartic acid
substrate inhibition
carbobenzoxy-L-phenylalanine-phosphonamidate-L-leucyl-L-alanine
a potent phosphonamidate transition state analogue inhibitor
N-(1-carboxy-3-phenyl-propyl)-L-leucyl-L-tryptophan
-
[(2S)-2-sulfanyl-3-phenylpropanoyl]Gly-(5-Ph)Pro
-
[(2S)-2-sulfanyl-3-phenylpropanoyl]Phe-Tyr
-
[(2S,R)-2-sulfanylheptanoyl]Phe-Ala
-
(E)-N-(naphthalen-1-yl)-N'-(4-oxo-2-phenylquinazolin-3(4H)-yl)acetimidamide
-
low inhibitory activity
1-beta-D-arabinofuranosyl-N4-lauroylcytosine
-
competitive
2-(4-chlorophenyl) quinazolin-4(3H)-one
-
low inhibitory activity
2-(4-methylphenyl) quinazolin-4(3H)-one
-
low inhibitory activity
2-(4-methylphenyl)-3-(1,3-thiazol-2-yl) quinazolin-4(3H)-one
-
-
2-(4-oxo-2-methylquinazolin-3(4H)-yl) guanidine
-
low inhibitory activity
2-(N-Bromoacetyl-N-hydroxyamino)-4-methylpentanonitrile
-
irreversible
2-benzamido-N-(3-(4-oxo-2-phenylquinazolin-3(4H)-yl)propyl)benzamide
-
low inhibitory activity
2-chloro-N-(2-methyl-4-oxoquinazolin-3(4H)-yl)acetamide
-
low inhibitory activity
2-ethylquinazolin-4(3H)-one
-
-
2-hydroxy-N-(4-methyl-2-nitrophenyl)-3-nitrobenzamide
-
competitive
2-phenyl-3-(1, 3-thiazol-2-yl) quinazolin-4(3H)-one
-
low inhibitory activity
2-phenyl-3-[[(1E)-phenylmethylene] amino]-2,3-dihydroquinazolin-4(1H)-one
-
low inhibitory activity
2-[(biphenyl-4-ylsulfonyl)[2-(hydroxyamino)-2-oxoethyl]amino]-N-[2-(4-sulfamoylphenyl)ethyl]acetamide (non-preferred name)
-
-
2-[benzyl[2-(hydroxyamino)-2-oxoethyl]amino]-N-[2-(4-sulfamoylphenyl)ethyl]acetamide (non-preferred name)
-
the phenyl group of the strong binder occupies the S'2-subpocket, while a second ring system occupy the S1-subpocket in both thermolysin and pseudolysin, EC 3.4.24.27
2-[benzyl[2-(hydroxyamino)-2-oxoethyl]amino]-N-[3-(4-phenylpiperazin-1-yl)propyl]acetamide (non-preferred name)
-
the phenyl group of the strong binder occupies the S'2-subpocket, while a second ring system occupy the S1-subpocket in both thermolysin and pseudolysin, EC 3.4.24.26
2-[[2-(hydroxyamino)-2-oxoethyl][(4-methoxyphenyl)sulfonyl]amino]-N-[2-(4-sulfamoylphenyl)ethyl]acetamide (non-preferred name)
-
-
2-[[2-(hydroxyamino)-2-oxoethyl][(4-phenoxyphenyl)sulfonyl]amino]-N-[2-(4-sulfamoylphenyl)ethyl]acetamide (non-preferred name)
-
-
3-(2-aminoethyl)-2-(4-methylphenyl) quinazolin-4(3H)-one
-
low inhibitory activity
3-(2-hydroxyethyl) quinazolin-4(3H)-one
-
low inhibitory activity
3-(3-aminopropyl)-2-(4-methylphenyl) quinazolin-4(3H)-one
-
low inhibitory activity
3-(4-iodophenyl)-2-phenylquinazolin-4(3H)-one
-
low inhibitory activity
3-(isopropylideneamino)-2,2-dimethyl-2,3-dihydroquinazolin-4(1H)-one
-
potent inhibitor
3-([(1E)-[4-(dimethylamino) phenyl]methylene]amino)-2-methylquinazolin-4(3H)-one
-
-
3-([(1E)-[4-(dimethylamino) phenyl]methylene]amino)-2-phenylquinazolin-4(3H)-one
-
-
3-amino-2-(4-chlorophenyl)quinazolin-4(3H)-one
-
-
3-amino-2-(4-nitrophenyl)quinazolin-4(3H)-one
-
-
3-amino-2-(hydrazinomethyl) quinazolin-4(3H)-one
-
low inhibitory activity
3-amino-2-(trifluoromethyl) quinazolin-4(3H)-one
-
-
3-amino-2-methylquinazolin-4(3H)-one
-
-
3-phenyl-2-(trifluoromethyl) quinazolin-4(3H)-one
-
potent inhibitor
3-Phenylpropionyl-L-Phe
-
crystallographic study of the binding to thermolysin
3-[[(1E)-(2-hydroxynaphthalen-1-yl)methylene]amino]-2-phenylquinazolin-4(3H)-one
-
low inhibitory activity
3-[[(1E)-(3-chlorophenyl)methylene]amino]-2-phenylquinazolin-4(3H)-one
-
-
3-[[(1E)-(4-fluorophenyl)methylene]amino]-2-phenylquinazolin-4(3H)-one
-
low inhibitory activity
4-methyl-N-(2-methyl-4-oxoquinazolin-3(4H)-yl)benzamide
-
low inhibitory activity
5-bromo-N-(4-bromophenyl)-2-hydroxy-3-nitro-benzamide
-
competitive
beta-phenylpropionyl-L-phenylalanine
-
-
Bifunctional N-carboxyalkyl dipeptides
-
-
-
carbobenzoxy-L-Phe
-
crystallographic study of the binding to thermolysin
Cbz-Gly-PSI[P(O)OH]-Leu-Leu
-
-
CBZ-Phe-PSI[P(O)OH]-Leu-Ala
-
-
ClCH2CO-DL-(N-OH)Leu-OCH3
-
specific, irreversible, pH-dependence of inhibition
Cu2+-Cys-Gly-His-Lys
-
stimulation at concentration up to 0.01 mM, inhibition at higher concentrations of 0.01-0.1 mM, binding and kinetics, overview
ethanimidic acid N-[4-oxo-2-phenyl-3(4H)-quinazolinyl]-ethyl ester
-
-
ethyl (4-oxo-3,4-dihydroquinazolin-2-yl)acetate
-
low inhibitory activity
HONH-benzylmalonyl-L-Ala-Gly-NH2
-
-
Hydroxamic acid inhibitors
-
binding to thermolysin suggests a pentacoordinate zinc intermediate
-
methyl 2-[(trifluoroacetyl) amino] benzoate
-
low inhibitory activity
N-(1-Carboxy-3-phenylpropyl)-Leu-Trp
-
-
N-(2,3-dimethylphenyl)-2-hydroxy-3-nitro-benzamide
-
competitive
N-(2,4-dimethylphenyl)-2-hydroxy-3-nitro-benzamide
-
competitive
N-(2,5-dimethylphenyl)-2-hydroxy-3-nitrobenzamide
-
competitive
N-(2-chloro-4-nitrophenyl)-2-hydroxy-3-nitro-benzamide
-
competitive
N-(2-chloro-6-methylphenyl)-2-hydroxy-3-nitrobenzamide
-
competitive
N-(2-ethylphenyl)-2-hydroxy-3-nitrobenzamide
-
competitive
N-(2-methyl-4-oxoquinazolin-3(4H)-yl)acetamide
-
low inhibitory activity
N-(2-methyl-4-oxoquinazolin-3(4H)-yl)benzamide
-
low inhibitory activity
N-(2-phenyl-4-oxoquinazolin-3(4H)-yl)acetamide
-
low inhibitory activity
N-(5-chloro-2-methoxyphenyl)-2-hydroxy-3-nitro-benzamide
-
competitive
N-chloroacetyl-N-hydroxyleucine methyl ester
-
irreversible inhibition
N-chloroacetyl-N-hydroxyleucyl-alanyl-glycinamide
-
irreversible inhibition
n-Pentanol
-
saturation concentration of activation at 60%, inhibition at higher concentration
N-Phosphoryl-Ile-Ala-OH
-
-
N-Phosphoryl-L-Leu-L-Trp
-
specific inhibitor
N-Phosphoryl-Leu-Phe-OH
-
-
N-Phosphoryl-Leu-Trp-OH
-
-
N-[(2R)-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl]-N-[(4-phenoxyphenyl)sulfonyl]glycine
-
-
N-[[[benzyloxycarbonyl]amino]methyl]hydroxyphosphinyl-L-Phe
-
-
Peptide hydroxamic acids
-
-
-
Peptides containing zinc coordination ligands
-
-
-
Z-L-phenylalanine
-
enzyme binding structure and kinetics, chemical shift of the carboxylate carbon upon enzyme binding, overview. The carbobenzyloxyl protecting group and not the phenylalanyl phenyl group that is bound in the S1' specificity pocket and the alpha carboxylate group is directly coordinated to the active site zinc atom
Z-L-tryptophan
-
inhibits full length stromelysin_1-477 and truncated stromelysin_100-264, enzyme binding structure and kinetics, chemical shift of the carboxylate carbon upon enzym ebinding, overview. The tryptophan side chain can bind in the S1 specificity site of stromelysin with the tryptophan alpha carboxylate group coordinated to the active site zinc atom. L-tryptophan binds equally strongly to zinc or cobalt substituted thermolysin
Zincov
-
competitive inhibitor
[(biphenyl-4-ylmethyl)[2-(hydroxyamino)-2-oxoethyl]amino]acetic acid
-
-
[(biphenyl-4-ylsulfonyl)[2-(hydroxyamino)-2-oxoethyl]amino]acetic acid
-
-
[1-[2-(hydroxyamino)-2-oxoethyl]-2-[3-(4-phenylpiperazin-1-yl)propyl]hydrazinyl]acetic acid
-
-
[Co(acacen)(NH3)2]Cl
-
irreversible inhibition
[[(4-methoxyphenyl)sulfonyl](2-oxo-2-[[2-(4-sulfamoylphenyl)ethyl]amino]ethyl)amino]acetic acid
-
-
[[2-(hydroxyamino)-2-oxoethyl](4-nitrobenzyl)amino]acetic acid
-
-
[[2-(hydroxyamino)-2-oxoethyl](4-phenoxybenzyl)amino]acetic acid
-
-
[[2-(hydroxyamino)-2-oxoethyl][(4-methoxyphenyl)sulfonyl]amino]acetic acid
-
-
[[2-(hydroxyamino)-2-oxoethyl][(4-phenoxyphenyl)sulfonyl]amino]acetic acid
-
-
Co2+
-
competitive, 72% inhibition at 18 mM, partial protection or reverse effect by Ca2+ at 0.5 mM, Co2+ show partly Ca2+-sensitive and partly Ca2+-insensitive inhibition, molecular mechanism, Co21 accelerates the autolysis, overview
Co2+
-
increases the activity 3-4fold at up to 2 mM, but inhibits at 2-18 mM, activation-and-inhibition dual effects of Co2+ ion are analysed kinetically
dipeptides
-
crystallographic study of the binding to thermolysin
dipeptides
-
overview, temperature dependence, pH-dependence
N-Phosphoryl-L-Leu amide
-
-
N-Phosphoryl-L-Leu amide
-
thermolysin-inhibitor complexes examined by NMR spectroscopy
Phosphonamidates
-
-
-
Phosphonamidates
-
overview
-
phosphoramidon
-
-
phosphoramidon
-
specific inhibitor
phosphoramidon
-
the OH-group is not essential for the binding to thermolysin
phosphoramidon
-
i.e. N-(alpha-L-rhamnopyranosyloxyphospho)-L-Leu-L-Trp, thermolysin-inhibitor complexes examined by NMR spectroscopy
phosphoramidon
-
crystallographic study of the complex of phosphoramidon with thermolysin
phosphoramidon
-
strong competitive inhibitor
additional information
not inhibited by 3-hydroxy-2-methylthieno[3,2-d]pyrimidine-4(3H)-one and 3-(acetylamino)-4-methylthiophene-2-carboxylic acid
-
additional information
binding of inhibitors to the active site of thermolysin, structure overview
-
additional information
-
identification of inhibitors by structure based virtual screening and study of binding modes by docking
-
additional information
-
not inhibited by 2-phenyl-3-[(E)-phenyldiazenyl]-1,2,3,4-tetrahydro-10H[1,2,4]triazino[6,1b]-quinazolin-10-one, 3-mesityl-2-phenylquinazolin-4(3H)-one, 3-(2-hydroxyethyl)-2-methylquinazolin-4(3H)-one, and 3-amino-2-phenylquinazolin-4(3H)-one
-
additional information
-
inhibitor synthesis, docking analysis and binding structure, molecular modeling, overview. When the compounds possess two ring systems, the largest and most electron rich ring system seems to occupy the S1-subpocket. The fourth zinc coordinating ligand in the free enzyme is a water molecule. Upon inhibitor binding this water molecule is replaced by a metal binding group of the inhibitor
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.38 - 0.49
N-carbobenzoxy-L-aspartyl-L-phenylalanine methyl ester
0.2
[3H]Tyr-Gly-Gly-Phe-Leu
pH 8.0, 37°C
0.002
(7-methoxycoumarin-4yl) acetyl-L-Pro-L-Leu-Gly-L-Leu-[N3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-L-Ala-L-Arg-NH2
-
pH and temperature not specified in the publication
0.00449
(europium(III) complex of a modified terpyridine)-K1K2K2GFSAK2K-black hole quencher 2
-
pH and temperature not specified in the publication
-
0.65 - 0.72
Benzyloxycarbonyl-(4-nitro)Phe-Leu-Ala
-
depending on mode of preparation of the form of enzyme
2.8
Benzyloxycarbonyl-Asp
-
pH 5.0 or pH 6.0
0.033 - 0.076
Benzyloxycarbonyl-Asp-Phe methyl ester
0.98 - 1.39
Benzyloxycarbonyl-Gly-Phe-Leu-Ala
-
depending on mode of preparation of the form of enzyme
0.55 - 1.52
Benzyloxycarbonyl-Phe-Leu-Ala
-
depending on mode of preparation of the form of enzyme
0.2
dansyl-Ala-Ala-Phe-Ala
-
-
0.91
dansyl-Ala-Phe-Ala
-
-
13
dansyl-Gly-Gly-Leu-Gly
-
-
0.69
dansyl-Gly-Leu-Phe
-
-
0.08 - 0.09
Dansyl-Gly-Phe-Ala
-
depending on assay method
0.77
dansyl-Gly-Phe-Gly
-
-
0.3
dansyl-Gly-Phe-Phe
-
-
250 - 300
L-Phe methyl ester
5.8 - 12.9
L-phenylalanine methyl ester
0.2 - 1.985
leucine enkephalin
0.00395
N,N'-diBoc-dityrosyl-(Ile-isoniazid)2
-
pH 7.5, 37°C
0.00191
N,N'-diBoc-dityrosyl-(Phe-isoniazid)2
-
pH 7.5, 37°C
20 - 39.2
N-(benzyloxycarbonyl)-L-Phe
0.42 - 0.57
N-benzyloxycarbonyl-L-Asp-L-Phe-methyl ester
10 - 20
N-carbobenzoxy-Gly-L-Leu-NH2
0.06 - 1.29
N-carbobenzoxy-L-Asp-L-Phe methyl ester
0.7 - 2.1
N-carbobenzoxy-L-Asp-L-Phe-methyl ester
49 - 105
N-carbobenzoxy-L-aspartic acid
0.77
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
mutant enzyme S53D, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
0.62
Phe-Leu-Ala-NH(CH2)2NH-dansyl
-
-
additional information
additional information
-
0.38
N-carbobenzoxy-L-aspartyl-L-phenylalanine methyl ester
purified recombinant mutant N116Q, pH 7.5, 25°C
0.39
N-carbobenzoxy-L-aspartyl-L-phenylalanine methyl ester
purified recombinant wild-type enzyme, pH 7.5, 25°C
0.41
N-carbobenzoxy-L-aspartyl-L-phenylalanine methyl ester
purified recombinant mutant N116A, pH 7.5, 25°C
0.48
N-carbobenzoxy-L-aspartyl-L-phenylalanine methyl ester
purified recombinant mutant N116D, pH 7.5, 25°C
0.49
N-carbobenzoxy-L-aspartyl-L-phenylalanine methyl ester
purified recombinant mutant N116T, pH 7.5, 25°C
0.033
Benzyloxycarbonyl-Asp-Phe methyl ester
-
pH 5.5
0.059
Benzyloxycarbonyl-Asp-Phe methyl ester
-
pH 6.0
0.076
Benzyloxycarbonyl-Asp-Phe methyl ester
-
pH 5.0
0.3
GFA
-
pH 8.0, 37°C
0.6
GFA
-
pH 8.0, 37°C, 5 M glycerol
0.4
GFL
-
pH 8.0, 37°C, product FL
0.7
GFL
-
pH 8.0, 37°C, 5 M glycerol, product GL
1.8
GFL
-
pH 8.0, 37°C, 5 M glycerol, product FL
2.5
GFL
-
pH 8.0, 37°C, 5 M glycerol, product GF
1.3
GFS
-
pH 8.0, 37°C
3.5
GFS
-
pH 8.0, 37°C, 5 M glycerol
0.7
GFSA
-
pH 8.0, 37°C, product FSA
1.2
GFSA
-
pH 8.0, 37°C, 5 M glycerol, product GF
6.8
GFSA
-
pH 8.0, 37°C, 5 M glycerol, product FSA
12
GFSA
-
pH 8.0, 37°C, 5 M glycerol, product GF
250
L-Phe methyl ester
-
pH 5.5 or 6.0
300
L-Phe methyl ester
-
-
5.8
L-phenylalanine methyl ester
-
mutant enzyme D150E, at pH 7.5, at 25°C
7
L-phenylalanine methyl ester
-
mutant enzyme D150W, at pH 7.5, at 25°C
7.3
L-phenylalanine methyl ester
-
mutant enzyme D150A, at pH 7.5, at 25°C
8.7
L-phenylalanine methyl ester
-
wild type enzyme, at pH 7.5, at 25°C
8.8
L-phenylalanine methyl ester
-
mutant enzyme N227H, at pH 7.5, at 25°C
11.3
L-phenylalanine methyl ester
-
mutant enzyme F114A, at pH 7.5, at 25°C
12.9
L-phenylalanine methyl ester
-
mutant enzyme I168A, at pH 7.5, at 25°C
0.2
leucine enkephalin
-
pH 6.8, 37°C, wild-type
0.21
leucine enkephalin
-
pH 7.4, 37°C, wild-type
0.24
leucine enkephalin
-
pH 6.8, 37°C, mutant D170A
0.24
leucine enkephalin
-
pH 6.8, 37°C, mutant R203M
0.48
leucine enkephalin
-
pH 7.4, 37°C, mutant Y157F
1.985
leucine enkephalin
-
pH 7.4, 37°C, mutant D226A
20
N-(benzyloxycarbonyl)-L-Phe
-
-
39.2
N-(benzyloxycarbonyl)-L-Phe
-
-
0.42
N-benzyloxycarbonyl-L-Asp-L-Phe-methyl ester
-
recombinant wild-type enzyme, pH 7.5, 25°C
0.44
N-benzyloxycarbonyl-L-Asp-L-Phe-methyl ester
-
recombinant mutant G117E, pH 7.5, 25°C
0.5
N-benzyloxycarbonyl-L-Asp-L-Phe-methyl ester
-
recombinant mutant G117R, pH 7.5, 25°C
0.57
N-benzyloxycarbonyl-L-Asp-L-Phe-methyl ester
-
recombinant mutant G117K, pH 7.5, 25°C
10
N-carbobenzoxy-Gly-L-Leu-NH2
-
mutant L155G, 37°C, pH 7.0
13
N-carbobenzoxy-Gly-L-Leu-NH2
-
mutant L155S, 37°C, pH 7.0
14
N-carbobenzoxy-Gly-L-Leu-NH2
-
wild-type, 37°C, pH 7.0
17
N-carbobenzoxy-Gly-L-Leu-NH2
-
mutant L155F, 37°C, pH 7.0
20
N-carbobenzoxy-Gly-L-Leu-NH2
-
mutant L155A, 37°C, pH 7.0
0.06
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.0, 25°C, recombinant mutant L144S
0.1
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.0, 25°C, recombinant mutant G8C/N60C/S65P/L144S
0.16
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme L144S/D150E/S53D, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
0.17
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme L144S/D150E, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
0.18
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.0, 25°C, recombinant mutant G8C/N60C/S65P
0.18
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme D150E/I168A, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
0.19
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme L144S, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
0.24
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.5, 25°C, recombinant mutant Q225V
0.28
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.5, 25°C, recombinant mutant Q128A
0.29
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.5, 25°C, recombinant mutant Q225A
0.3
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.5, 25°C, recombinant mutants Q128K and Q225R
0.33
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.0, 25°C, recombinant wild-type enzyme
0.33
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.5, 25°C, recombinant mutant Q128E
0.34
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.5, 25°C, recombinant mutant Q225D
0.39
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.5, 25°C, recombinant mutant Q225K
0.4
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.5, 25°C, recombinant enzyme
0.4
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.5, 25°C, recombinant wild-type enzyme
0.45
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.5, 25°C, recombinant wild-type enzyme
0.46
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme I168A, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
0.5
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme D150E, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
0.52
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.5, 25°C, native enzyme
0.52
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.5, 25°C, native wild-type enzyme
0.54
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme G8C/N60C/S65P, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
0.55
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme S53D/L155A/G8C/N60C/S65P, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
0.63
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.5, 25°C, recombinant mutant Q225E
0.63
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
wild type enzyme, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
0.69
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme S53D/L155A, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
0.83
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme L155A/G8C/N60C/S65P, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
0.94
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme S53D/G8C/N60C/S65P, in the absence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
1.29
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme L155A, in the absence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
0.7
N-carbobenzoxy-L-Asp-L-Phe-methyl ester
-
mutant enzyme D150E, at pH 7.5, at 25°C
0.8
N-carbobenzoxy-L-Asp-L-Phe-methyl ester
-
mutant enzyme I168A, at pH 7.5, at 25°C
1
N-carbobenzoxy-L-Asp-L-Phe-methyl ester
-
mutant enzyme F114A, at pH 7.5, at 25°C
1
N-carbobenzoxy-L-Asp-L-Phe-methyl ester
-
wild type enzyme, at pH 7.5, at 25°C
1.3
N-carbobenzoxy-L-Asp-L-Phe-methyl ester
-
mutant enzyme N227H, at pH 7.5, at 25°C
2.1
N-carbobenzoxy-L-Asp-L-Phe-methyl ester
-
mutant enzyme D150A, at pH 7.5, at 25°C
2.1
N-carbobenzoxy-L-Asp-L-Phe-methyl ester
-
mutant enzyme D150W, at pH 7.5, at 25°C
49
N-carbobenzoxy-L-aspartic acid
-
mutant enzyme F114A, at pH 7.5, at 25°C
54
N-carbobenzoxy-L-aspartic acid
-
mutant enzyme D150W, at pH 7.5, at 25°C
57
N-carbobenzoxy-L-aspartic acid
-
mutant enzyme D150A, at pH 7.5, at 25°C
60
N-carbobenzoxy-L-aspartic acid
-
mutant enzyme D150E, at pH 7.5, at 25°C
62
N-carbobenzoxy-L-aspartic acid
-
wild type enzyme, at pH 7.5, at 25°C
70
N-carbobenzoxy-L-aspartic acid
-
mutant enzyme N227H, at pH 7.5, at 25°C
105
N-carbobenzoxy-L-aspartic acid
-
mutant enzyme I168A, at pH 7.5, at 25°C
additional information
additional information
Michaelis-Menten kinetics
-
additional information
additional information
thermodynamics of wild-type and mutant enzymes
-
additional information
additional information
steady-state kinetics, overview
-
additional information
additional information
-
-
-
additional information
additional information
-
kinetics
-
additional information
additional information
-
kinetics
-
additional information
additional information
-
overview: Km of synthetic oligopeptides
-
additional information
additional information
-
effect of various n-pentanal concentrations of Km
-
additional information
additional information
-
Michaelis-Menten kinetics, overview
-
additional information
additional information
-
Michaelis-Menten kinetics, overview
-
additional information
additional information
-
kinetics and thermodynamics of wild-type and mutant enzymes in absence or presence of salt, overview
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
5.4 - 12
N-carbobenzoxy-L-aspartyl-L-phenylalanine methyl ester
2.36
(7-methoxycoumarin-4yl) acetyl-L-Pro-L-Leu-Gly-L-Leu-[N3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-L-Ala-L-Arg-NH2
-
pH and temperature not specified in the publication
2.6
(europium(III) complex of a modified terpyridine)-K1K2K2GFSAK2K-black hole quencher 2
-
pH and temperature not specified in the publication
-
861 - 951
Benzyloxycarbonyl-(4-nitro)Phe-Leu-Ala
-
depending on mode of preparation of the form of enzyme
407 - 968
Benzyloxycarbonyl-Gly-Phe-Leu-Ala
-
depending on mode of preparation of the form of enzyme
362 - 605
Benzyloxycarbonyl-Phe-Leu-Ala
-
depending on mode of preparation of the form of enzyme
1.4 - 1.7
Dansyl-Gly-Phe-Ala
-
depending on assay method
0.3 - 4.9
L-phenylalanine methyl ester
0.083 - 1560
leucine enkephalin
0.238
N,N'-diBoc-dityrosyl-(Ile-isoniazid)2
-
pH 7.5, 37°C
0.0463
N,N'-diBoc-dityrosyl-(Phe-isoniazid)2
-
pH 7.5, 37°C
0.556 - 1.69
N-(benzyloxycarbonyl)-L-Phe
4.8 - 10.5
N-benzyloxycarbonyl-L-Asp-L-Phe-methyl ester
23.3 - 165
N-carbobenzoxy-Gly-L-Leu-NH2
1.3 - 17
N-carbobenzoxy-L-Asp-L-Phe methyl ester
1.5 - 49.4
N-carbobenzoxy-L-Asp-L-Phe-methyl ester
0.3 - 4.9
N-carbobenzoxy-L-aspartic acid
6.9
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
mutant enzyme S53D, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
additional information
additional information
-
5.4
N-carbobenzoxy-L-aspartyl-L-phenylalanine methyl ester
purified recombinant mutant N116T, pH 7.5, 25°C
6.7
N-carbobenzoxy-L-aspartyl-L-phenylalanine methyl ester
purified recombinant mutant N116A, pH 7.5, 25°C
7.1
N-carbobenzoxy-L-aspartyl-L-phenylalanine methyl ester
purified recombinant mutant N116Q, pH 7.5, 25°C
7.7
N-carbobenzoxy-L-aspartyl-L-phenylalanine methyl ester
purified recombinant wild-type enzyme, pH 7.5, 25°C
12
N-carbobenzoxy-L-aspartyl-L-phenylalanine methyl ester
purified recombinant mutant N116D, pH 7.5, 25°C
0.06
GFA
-
pH 8.0, 37°C
0.076
GFA
-
pH 8.0, 37°C, 5 M glycerol
0.006
GFL
-
pH 8.0, 37°C, 5 M glycerol, product GF
0.013
GFL
-
pH 8.0, 37°C, product GF
0.026
GFL
-
pH 8.0, 37°C, 5 M glycerol, product FL
0.045
GFL
-
pH 8.0, 37°C, product FL
0.035
GFS
-
pH 8.0, 37°C
0.05
GFS
-
pH 8.0, 37°C, 5 M glycerol
0.07
GFSA
-
pH 8.0, 37°C, product FSA
0.173
GFSA
-
pH 8.0, 37°C, 5 M glycerol, product FSA
0.3
GFSA
-
pH 8.0, 37°C, product GF
0.591
GFSA
-
pH 8.0, 37°C, 5 M glycerol, product GF
6.08
GFSA
-
pH 8.0, 37°C, 5 M glycerol, product GF
0.3
L-phenylalanine methyl ester
-
mutant enzyme F114A, at pH 7.5, at 25°C
1.3
L-phenylalanine methyl ester
-
wild type enzyme, at pH 7.5, at 25°C
2.1
L-phenylalanine methyl ester
-
mutant enzyme D150A, at pH 7.5, at 25°C
2.3
L-phenylalanine methyl ester
-
mutant enzyme N227H, at pH 7.5, at 25°C
2.5
L-phenylalanine methyl ester
-
mutant enzyme D150E, at pH 7.5, at 25°C
3.2
L-phenylalanine methyl ester
-
mutant enzyme D150W, at pH 7.5, at 25°C
4.9
L-phenylalanine methyl ester
-
mutant enzyme I168A, at pH 7.5, at 25°C
0.083
leucine enkephalin
-
pH 6.8, 37°C, mutant R203M
2.94
leucine enkephalin
-
pH 6.8, 37°C, mutant D170A
2.94
leucine enkephalin
-
pH 7.4, 37°C, mutant Y157F
155.5
leucine enkephalin
-
pH 7.4, 37°C, wild-type
156
leucine enkephalin
-
pH 7.4, 37°C, wild-type
1555
leucine enkephalin
-
pH 6.8, 37°C, wild-type
1560
leucine enkephalin
-
pH 6.8, 37°C, wild-type
0.556
N-(benzyloxycarbonyl)-L-Phe
-
-
1.69
N-(benzyloxycarbonyl)-L-Phe
-
-
4.8
N-benzyloxycarbonyl-L-Asp-L-Phe-methyl ester
-
recombinant mutant G117R, pH 7.5, 25°C
7.9
N-benzyloxycarbonyl-L-Asp-L-Phe-methyl ester
-
recombinant wild-type enzyme, pH 7.5, 25°C
8.4
N-benzyloxycarbonyl-L-Asp-L-Phe-methyl ester
-
recombinant mutant G117K, pH 7.5, 25°C
10.5
N-benzyloxycarbonyl-L-Asp-L-Phe-methyl ester
-
recombinant mutant G117E, pH 7.5, 25°C
23.3
N-carbobenzoxy-Gly-L-Leu-NH2
-
mutant L155F, 37°C, pH 7.0
51.6
N-carbobenzoxy-Gly-L-Leu-NH2
-
wild-type, 37°C, pH 7.0
80
N-carbobenzoxy-Gly-L-Leu-NH2
-
mutant L155A, 37°C, pH 7.0
150
N-carbobenzoxy-Gly-L-Leu-NH2
-
mutant L155G, 37°C, pH 7.0
165
N-carbobenzoxy-Gly-L-Leu-NH2
-
mutant L155S, 37°C, pH 7.0
1.3
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.5, 25°C, recombinant mutant Q225A
1.6
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.5, 25°C, recombinant mutant Q225V
3.3
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.0, 25°C, recombinant mutant G8C/N60C/S65P
3.3
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.5, 25°C, recombinant mutant Q225D
3.3
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme S53D/L155A/G8C/N60C/S65P, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
3.4
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.0, 25°C, recombinant wild-type enzyme
3.6
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.5, 25°C, recombinant mutant Q225R
3.7
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.5, 25°C, recombinant mutant Q128K
3.8
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.5, 25°C, recombinant enzyme
3.8
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.5, 25°C, recombinant wild-type enzyme
3.8
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.5, 25°C, recombinant mutant Q128A
4.3
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.5, 25°C, native enzyme
4.3
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.5, 25°C, native wild-type enzyme
4.3
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.5, 25°C, recombinant mutants Q128E and Q225E
4.7
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.5, 25°C, recombinant wild-type enzyme and mutant Q225K
5.4
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme G8C/N60C/S65P, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
5.9
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
wild type enzyme, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
6.3
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme L155A/G8C/N60C/S65P, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
6.4
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme S53D/L155A, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
6.7
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.0, 25°C, recombinant mutant L144S
7
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
pH 7.0, 25°C, recombinant mutant G8C/N60C/S65P/L144S
7.4
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme S53D/G8C/N60C/S65P, in the absence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
7.7
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme I168A, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
8.7
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme L155A, in the absence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
9.4
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme L144S, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
15.5
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme D150E/I168A, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
15.6
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme L144S/D150E/S53D, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
16.5
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme D150E, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
17
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme L144S/D150E, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
1.5
N-carbobenzoxy-L-Asp-L-Phe-methyl ester
-
mutant enzyme F114A, at pH 7.5, at 25°C
9.5
N-carbobenzoxy-L-Asp-L-Phe-methyl ester
-
wild type enzyme, at pH 7.5, at 25°C
12.3
N-carbobenzoxy-L-Asp-L-Phe-methyl ester
-
mutant enzyme I168A, at pH 7.5, at 25°C
17.1
N-carbobenzoxy-L-Asp-L-Phe-methyl ester
-
mutant enzyme N227H, at pH 7.5, at 25°C
20.5
N-carbobenzoxy-L-Asp-L-Phe-methyl ester
-
mutant enzyme D150E, at pH 7.5, at 25°C
24.4
N-carbobenzoxy-L-Asp-L-Phe-methyl ester
-
mutant enzyme D150A, at pH 7.5, at 25°C
49.4
N-carbobenzoxy-L-Asp-L-Phe-methyl ester
-
mutant enzyme D150W, at pH 7.5, at 25°C
0.3
N-carbobenzoxy-L-aspartic acid
-
mutant enzyme F114A, at pH 7.5, at 25°C
1.3
N-carbobenzoxy-L-aspartic acid
-
wild type enzyme, at pH 7.5, at 25°C
2.1
N-carbobenzoxy-L-aspartic acid
-
mutant enzyme D150A, at pH 7.5, at 25°C
2.3
N-carbobenzoxy-L-aspartic acid
-
mutant enzyme N227H, at pH 7.5, at 25°C
2.5
N-carbobenzoxy-L-aspartic acid
-
mutant enzyme D150E, at pH 7.5, at 25°C
3.2
N-carbobenzoxy-L-aspartic acid
-
mutant enzyme D150W, at pH 7.5, at 25°C
4.9
N-carbobenzoxy-L-aspartic acid
-
mutant enzyme I168A, at pH 7.5, at 25°C
additional information
additional information
-
effect of various n-pentanal concentrations of turnover number
-
additional information
additional information
-
overview: turnover number of synthetic oligopeptides
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
11 - 27
N-carbobenzoxy-L-aspartyl-L-phenylalanine methyl ester
26 - 117
N-[3-(2-furyl)acryloyl]-glycyl-L-leucine amide
60.3
N,N'-diBoc-dityrosyl-(Ile-isoniazid)2
-
pH 7.5, 37°C
24.3
N,N'-diBoc-dityrosyl-(Phe-isoniazid)2
-
pH 7.5, 37°C
9.6 - 23.9
N-benzyloxycarbonyl-L-Asp-L-Phe-methyl ester
6 - 99
N-carbobenzoxy-L-Asp-L-Phe methyl ester
1.5 - 27.6
N-carbobenzoxy-L-Asp-L-Phe-methyl ester
0.23 - 11.7
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
15 - 40
N-[3-(2-furyl)acryloyl]-glycyl-L-leucine amide
11
N-carbobenzoxy-L-aspartyl-L-phenylalanine methyl ester
purified recombinant mutant N116T, pH 7.5, 25°C
16
N-carbobenzoxy-L-aspartyl-L-phenylalanine methyl ester
purified recombinant mutant N116A, pH 7.5, 25°C
19
N-carbobenzoxy-L-aspartyl-L-phenylalanine methyl ester
purified recombinant mutant N116Q, pH 7.5, 25°C
20
N-carbobenzoxy-L-aspartyl-L-phenylalanine methyl ester
purified recombinant wild-type enzyme, pH 7.5, 25°C
27
N-carbobenzoxy-L-aspartyl-L-phenylalanine methyl ester
purified recombinant mutant N116D, pH 7.5, 25°C
26
N-[3-(2-furyl)acryloyl]-glycyl-L-leucine amide
purified recombinant mutant N116T, pH 7.5, 25°C
31
N-[3-(2-furyl)acryloyl]-glycyl-L-leucine amide
purified recombinant mutant N116A, pH 7.5, 25°C
37
N-[3-(2-furyl)acryloyl]-glycyl-L-leucine amide
purified recombinant mutant N116Q, pH 7.5, 25°C
37
N-[3-(2-furyl)acryloyl]-glycyl-L-leucine amide
purified recombinant wild-type enzyme, pH 7.5, 25°C
117
N-[3-(2-furyl)acryloyl]-glycyl-L-leucine amide
purified recombinant mutant N116D, pH 7.5, 25°C
9.6
N-benzyloxycarbonyl-L-Asp-L-Phe-methyl ester
-
recombinant mutant G117R, pH 7.5, 25°C
14.7
N-benzyloxycarbonyl-L-Asp-L-Phe-methyl ester
-
recombinant mutant G117K, pH 7.5, 25°C
18.8
N-benzyloxycarbonyl-L-Asp-L-Phe-methyl ester
-
recombinant wild-type enzyme, pH 7.5, 25°C
23.9
N-benzyloxycarbonyl-L-Asp-L-Phe-methyl ester
-
recombinant mutant G117E, pH 7.5, 25°C
6
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme S53D/L155A/G8C/N60C/S65P, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
6.7
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme L155A, in the absence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
7.5
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme L155A/G8C/N60C/S65P, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
7.9
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme S53D/G8C/N60C/S65P, in the absence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
9.2
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme S53D/L155A, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
9.4
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
wild type enzyme, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
10
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme G8C/N60C/S65P, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
16.8
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme I168A, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
33.1
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme D150E, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
49.7
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme L144S, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
96.2
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme L144S/D150E/S53D, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
99
N-carbobenzoxy-L-Asp-L-Phe methyl ester
-
mutant enzyme L144S/D150E, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
1.5
N-carbobenzoxy-L-Asp-L-Phe-methyl ester
-
mutant enzyme F114A, at pH 7.5, at 25°C
9.3
N-carbobenzoxy-L-Asp-L-Phe-methyl ester
-
wild type enzyme, at pH 7.5, at 25°C
11.7
N-carbobenzoxy-L-Asp-L-Phe-methyl ester
-
mutant enzyme D150A, at pH 7.5, at 25°C
13.7
N-carbobenzoxy-L-Asp-L-Phe-methyl ester
-
mutant enzyme N227H, at pH 7.5, at 25°C
16
N-carbobenzoxy-L-Asp-L-Phe-methyl ester
-
mutant enzyme I168A, at pH 7.5, at 25°C
23
N-carbobenzoxy-L-Asp-L-Phe-methyl ester
-
mutant enzyme D150W, at pH 7.5, at 25°C
27.6
N-carbobenzoxy-L-Asp-L-Phe-methyl ester
-
mutant enzyme D150E, at pH 7.5, at 25°C
0.23
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
mutant enzyme S53D/L155A/G8C/N60C/S65P, in the absence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
0.26
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
mutant enzyme L155A, in the absence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
0.29
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
mutant enzyme G8C/N60C/S65P, in the absence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
0.29
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
wild type enzyme, in the absence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
0.31
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
mutant enzyme S53D/G8C/N60C/S65P, in the absence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
0.32
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
mutant enzyme S53D, in the absence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
0.33
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
mutant enzyme S53D/L155A, in the absence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
0.34
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
mutant enzyme L155A/G8C/N60C/S65P, in the absence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
0.62
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
mutant enzyme I168A, in the absence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
0.79
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
mutant enzyme D150E, in the absence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
1.82
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
mutant enzyme L144S, in the absence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
2.04
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
mutant enzyme L144S/D150E, in the absence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
2.1
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
mutant enzyme L155A, in the presence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
2.49
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
mutant enzyme L144S/D150E/S53D, in the absence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
3
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
mutant enzyme I168A, in the presence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
3.2
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
mutant enzyme S53D/L155A, in the presence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
3.3
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
mutant enzyme S53D/L155A/G8C/N60C/S65P, in the presence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
3.5
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
mutant enzyme G8C/N60C/S65P, in the presence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
3.8
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
wild type enzyme, in the presence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
3.9
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
mutant enzyme S53D, in the presence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
4
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
mutant enzyme D150E, in the presence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
4
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
mutant enzyme S53D/G8C/N60C/S65P, in the presence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
4.3
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
mutant enzyme L155A/G8C/N60C/S65P, in the presence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
6
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
mutant enzyme L144S/D150E, in the presence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
6.6
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
mutant enzyme L144S, in the presence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
9
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
mutant enzyme S53D, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
11.7
N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
-
mutant enzyme L144S/D150E/S53D, in the presence of 4 M NaCl, in 40 mM HEPES-NaOH buffer at pH 7.5 containing 10 mM CaCl2, at 25°C
15
N-[3-(2-furyl)acryloyl]-glycyl-L-leucine amide
-
recombinant mutant G117R, pH 7.5, 25°C
16
N-[3-(2-furyl)acryloyl]-glycyl-L-leucine amide
-
recombinant mutant G117K, pH 7.5, 25°C
33
N-[3-(2-furyl)acryloyl]-glycyl-L-leucine amide
-
recombinant mutant G117E, pH 7.5, 25°C
40
N-[3-(2-furyl)acryloyl]-glycyl-L-leucine amide
-
recombinant wild-type enzyme, pH 7.5, 25°C
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
N112A
no enzymic activity in supernatant of cells expressing mutant
N112D
supernatants of cells expressing mutant show 18% of wild-type activity
N112E
supernatants of cells expressing mutant show 5% of wild-type activity
N112H
no enzymic activity in supernatant of cells expressing mutant
N112K
no enzymic activity in supernatant of cells expressing mutant
N112R
no enzymic activity in supernatant of cells expressing mutant
N116A
site-directed mutagenesis, the mutant shows slightly decreased activity compared to the wild-type enzyme
N116D
site-directed mutagenesis, the mutant shows increased activity compared to the wild-type enzyme
N116Q
site-directed mutagenesis, the mutant shows unaltered activity compared to the wild-type enzyme
N116T
site-directed mutagenesis, the mutant shows slightly decreased activity compared to the wild-type enzyme
S198D
site directed mutagenesis, the mutant shows similar activity compared to the wild-type enzyme
S218D
site directed mutagenesis, the mutant shows similar activity compared to the wild-type enzyme
S254D
site directed mutagenesis, the mutant shows similar activity compared to the wild-type enzyme
S25D
site directed mutagenesis, the catalytic activity is of the mutant enzyme is similar to the wild-type in absence of NaCl, but increased in presence of 4 M NaCl
S53D
site directed mutagenesis, the catalytic activity is of the mutant enzyme is similar to the wild-type in absence of NaCl, but increased in presence of 4 M NaCl, increased thermostability in presence of 10 mM CaCl2
S65D
site directed mutagenesis, the catalytic activity is of the mutant enzyme is similar to the wild-type in absence of NaCl, but increased in presence of 4 M NaCl, increased thermostability in presence of 10 mM CaCl2
A113D
-
complete loss of activity
A113E
-
complete loss of activity
A113H
-
complete loss of activity
A113K
-
complete loss of activity
A113R
-
complete loss of activity
A4T/G8C/T56A/G58A/N60C/T63F/S65P/A69P
-
the mutant shows altered thermodynamics
A4T/T56A/G58A/T63F/S65P/A69P
-
the mutant shows altered thermodynamics
D150H
-
105% residual activity with casein, 37% residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide. Thermal inactivation at 80°C is greatly suppressed
D150K
-
51% residual activity with casein, no residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
D150R
-
44% residual activity with casein, no residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
D170E
-
complete loss of activity
D170H
-
complete loss of activity
D170K
-
complete loss of activity
D170R
-
complete loss of activity
D226A
-
site-directed mutagenesis
DELTA127
-
absence of CaCl2, 18% of wild-type activity, presence of 5 mM CaCl2, 71% of wild-type activity. Decrease in amount of enzyme secreted compared to wild-type
E143A
-
site-directed mutagenesis, E143A might exist as a complex with the propetide in the supernatant, inactive mutant, the autocatalytic activity is affected
F114D
-
complete loss of activity
F114E
-
complete loss of activity
F114H
-
18% residual activity with casein, 20% residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
F114K
-
complete loss of activity
F114R
-
complete loss of activity
G117D
-
site-directed mutagenesis, the mutant enzyme shows reduced activity compared to the wild-type
G117E
-
site-directed mutagenesis, the mutant enzyme shows increased activity compared to the wild-type enzyme, the kcat/Km value is 80% of wild-type level with N-[3-(2-furyl)acryloyl]-glycyl-L-leucine amide, but 130% with N-benzyloxycarbonyl-L-Asp-L-Phe-methyl ester
G117K
-
site-directed mutagenesis, the mutant enzyme shows reduced activity compared to the wild-type, the kcat/Km value is 40% of wild-type level with N-[3-(2-furyl)acryloyl]-glycyl-L-leucine amide, but 80% with N-benzyloxycarbonyl-L-Asp-L-Phe-methyl ester
G117R
-
site-directed mutagenesis, the mutant enzyme shows reduced activity compared to the wild-type, the kcat/Km value is 40% of wild-type level with N-[3-(2-furyl)acryloyl]-glycyl-L-leucine amide and N-benzyloxycarbonyl-L-Asp-L-Phe-methyl ester
G162A
-
complete loss of activity
G162D
-
complete loss of activity
G162E
-
complete loss of activity
G162H
-
complete loss of activity
G162K
-
complete loss of activity
G162R
-
complete loss of activity
G8C/N60C
-
the mutant shows altered thermodynamics
H231A
-
the mutant shows 500fold decreased catalytic efficiency compared to the wild-type enzyme
I168D
-
complete loss of activity
I168E
-
complete loss of activity
I168H
-
13% residual activity with casein, 35% residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide. Thermal inactivation at 80°C is greatly suppressed
I168K
-
complete loss of activity
I168R
-
complete loss of activity
L144S/D150E
-
the mutation yields the most significant increase in the hydrolytic activities for N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide and N-carbobenzoxy-L-Asp-L-Phe methyl ester and shows about 30% casein-hydrolytic activity compared to the wild type enzyme
L144S/D150E/I168A/S53D/L155A/G8C/N60C/S65P
-
inactive
L144S/D150E/L155A
-
inactive
L144S/D150E/S53D
-
the triple mutant shows improved activity and stability with about 30% casein-hydrolytic activity compared to the wild type enzyme
L144S/D150E/S53D/L155A
-
inactive
L144S/D150W/N227H
-
the mutant shows 10fold decreased catalytic efficiency compared to the wild-type enzyme
L144S/I168A
-
the mutation abolishes the hydrolytic activities for N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide and N-carbobenzoxy-L-Asp-L-Phe methyl ester
L155A/G8C/N60C/S65P
-
the mutant shows about 80% casein-hydrolytic activity compared to the wild type enzyme
L155F
-
thermostability at 80°C increases with amino acid substitutions at L155 in the order of wild-type, Gly, Ser, Phe, Ala. Autodegradation site shifts from G154-L155 to F155-I156 and the bond I164-D165 is newly recognized as an autodegradation site
L155G
-
thermostability at 80°C increases with amino acid substitutions at L155 in the order of wild-type, Gly, Ser, Phe, Ala. Autodegradation site shifts from G154-L155 to G155-I156 and the bond I164-D165 is newly recognized as an autodegradation site
M205P
-
absence of CaCl2, 0.52% of wild-type activity, presence of 5 mM CaCl2, 48% of wild-type activity. Decrease in amount of enzyme secreted compared to wild-type
N112A
-
site-directed mutagenesis, inactive mutant, the autocatalytic activity is affected
N112E
-
site-directed mutagenesis, the autocatalytic activity is affected
N112H
-
site-directed mutagenesis, inactive mutant, the autocatalytic activity is affected
N112K
-
site-directed mutagenesis, inactive mutant, the autocatalytic activity is affected
N112R
-
site-directed mutagenesis, inactive mutant, the autocatalytic activity is affected
N116D/Q119R/D150Q/Q225R
-
the mutant shows 4fold decreased catalytic efficiency compared to the wild-type enzyme
N227A
-
72% residual activity with casein , 28% residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide. Thermal inactivation at 80°C is greatly suppressed
N227D
-
11% residual activity with casein, no residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
N227E
-
36% residual activity with casein, no residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
N227K
-
29% residual activity with casein, no residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
N227R
-
55% residual activity with casein, no residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
P208H
-
absence of CaCl2, 0.61% of wild-type activity, presence of 5 mM CaCl2, 61% of wild-type activity. Decrease in amount of enzyme secreted compared to wild-type
Q128A
-
site-directed mutagenesis, the mutant shows slightly reduced activity compared to the wild-type enzyme
Q128E
-
site-directed mutagenesis, the mutant shows similar activity compared to the wild-type enzyme
Q128K
-
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
Q225A
-
site-directed mutagenesis, the mutant shows altered pKa value and stimulation of activity by NaCl and reduced activity with the negatively charged substrate N-carbobenzoxy-L-aspartyl-L-phenylalanine methyl ester substrate compared to the wild-type enzyme
Q225D
-
site-directed mutagenesis, the mutant shows increased activity compared to the wild-type enzyme
Q225E
-
site-directed mutagenesis, the mutant shows similar activity compared to the wild-type enzyme
Q225K
-
site-directed mutagenesis, the mutant shows slightly reduced activity compared to the wild-type enzyme
Q225R
-
site-directed mutagenesis, the mutant shows similar activity compared to the wild-type enzyme
Q225V
-
site-directed mutagenesis, the mutant shows altered pKa value and stimulation of activity by NaCl and reduced activity with the negatively charged substrate N-carbobenzoxy-L-aspartyl-L-phenylalanine methyl ester substrate compared to the wild-type enzyme
R203A
-
the mutant shows 5fold decreased catalytic efficiency compared to the wild-type enzyme
S103A
-
the mutant shows 3fold decreased catalytic efficiency compared to the wild-type enzyme
S169A
-
112% residual activity with casein, 64% residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
S169D
-
complete loss of activity
S169E
-
complete loss of activity
S169H
-
complete loss of activity
S169K
-
complete loss of activity
S169R
-
complete loss of activity
S234A
-
88% residual activity with casein, 17% residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide. Thermal inactivation at 80°C is greatly suppressed
S234D
-
5% residual activity with casein, no residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
S234E
-
4% residual activity with casein, 7% residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
S234H
-
32% residual activity with casein, no residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
S234K
-
complete loss of activity
S234R
-
complete loss of activity
S53D
-
the mutation increases the stability of thermolysin
S53D/G8C/N60C/S65P
-
the mutant shows about 110% casein-hydrolytic activity compared to the wild type enzyme
S53D/L155A
-
the mutation yields the greatest increase in the thermal stability and shows about 90% casein-hydrolytic activity compared to the wild type enzyme
S53D/L155A/G8C/N60C/S65P
-
the mutant shows about 70% casein-hydrolytic activity compared to the wild type enzyme
V230A
-
17% residual activity with casein, no residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
V230D
-
complete loss of activity
V230E
-
complete loss of activity
V230H
-
complete loss of activity
V230K
-
3% residual activity with casein, no residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
V230R
-
6% residual activity with casein, 12% residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
W115A
-
complete loss of activity
W115D
-
complete loss of activity
W115E
-
complete loss of activity
W115H
-
complete loss of activity
W115K
-
complete loss of activity
W115R
-
complete loss of activity
Y157A
-
11% residual activity with casein, no residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
Y157D
-
1% residual activity with casein, no residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
Y157E
-
13% residual activity with casein, no residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
Y157F
-
site-directed mutagenesis
Y157H
-
24% residual activity with casein, no residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
Y157K
-
7% residual activity with casein, no residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
Y157R
-
complete loss of activity
D150A
-
131% residual activity with casein, 81% residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
D150A
-
mutant with improved activity, the mutant has higher kcat values in N-carbobenzoxy-L-Asp-L-Phe-methyl ester synthesis than wild type
D150E
-
128% residual activity with casein, 228% residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
D150E
-
mutant with improved activity, the mutant has higher kcat values in N-carbobenzoxy-L-Asp-L-Phe-methyl ester synthesis than wild type
D150E
-
the mutation increases the activity of thermolysin
D150W
-
81% residual activity with casein, 60% residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide. Thermal inactivation at 80°C is greatly suppressed
D150W
-
mutant with improved activity, the mutant has higher kcat values in N-carbobenzoxy-L-Asp-L-Phe-methyl ester synthesis than wild type
D170A
-
complete loss of activity
D170A
-
site-directed mutagenesis
F114A
-
mutant with reduced activity
F114A
-
28% residual activity with casein, 8% residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide
G8C/N60C/S65P
-
site-directed mutagenesis, the mutant shows a similar catalytic efficiency compared tot he wild-type enzyme
G8C/N60C/S65P
-
the mutation increases the stability of thermolysin
G8C/N60C/S65P
-
the triple mutation increases the stability of thermolysin as high as the individual mutations do
G8C/N60C/S65P/L144S
-
site-directed mutagenesis, the mutant shows about 6fold increased catalytic effiency compared to the wild-type enzyme
G8C/N60C/S65P/L144S
-
the mutant is more active and stable than wild type thermolysin
I168A
-
69% residual activity with casein, 125% residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide. Thermal inactivation at 80°C is greatly suppressed
I168A
-
mutant with improved activity, the mutant has higher kcat values in N-carbobenzoxy-L-Asp-L-Phe-methyl ester synthesis than wild type
I168A
-
the mutation increases the activity of thermolysin and shows about 90% casein-hydrolytic activity compared to the wild type enzyme
L144S
-
site-directed mutagenesis, the mutant shows about 10fold increased catalytic effiency compared to the wild-type enzyme
L144S
-
the mutation increases the activity of thermolysin and shows about 30% casein-hydrolytic activity compared to the wild type enzyme
L155A
-
absence of CaCl2, 87% of wild-type activity, presence of 5 mM CaCl2, 83% of wild-type activity. Amount of enzyme secreted is about the same level as wild-type
L155A
-
thermostability at 80°C increases with amino acid substitutions at L155 in the order of wild-type, Gly, Ser, Phe, Ala. Autodegradation site shifts from G154-L155 to A155-I156 and the bond I164-D165 is newly recognized as an autodegradation site
L155A
-
the mutation increases the stability of thermolysin and shows about 60% casein-hydrolytic activity compared to the wild type enzyme
L155S
-
thermostability at 80°C increases with amino acid substitutions at L155 in the order of wild-type, Gly, Ser, Phe, Ala. Autodegradation site shifts from G154-L155 to S155-I156 and the bond I164-D165 is newly recognized as an autodegradation site
L155S
-
the mutant shows increased stability at 80°C compared to the wild-type enzyme
N112D
-
site-directed mutagenesis, the autocatalytic activity is affected
N112D
-
the mutant shows an altered pKa value
N227H
-
19% residual activity with casein, 19% residual activity with substrate N-[3-(2-furyl)acryloyl]-Gly-L-Leu amide. Thermal inactivation at 80°C is greatly suppressed
N227H
-
mutant with improved activity, the mutant has higher kcat values in N-carbobenzoxy-L-Asp-L-Phe-methyl ester synthesis than wild type
R203M
-
site-directed mutagenesis
R203M
-
the mutant shows 2300fold decreased catalytic efficiency compared to the wild-type enzyme
additional information
-
a mutant thermolysin is affected by its autocatalytic digestion activity
additional information
-
generation of an engineered enzyme with a higher activity in the synthesis of N-carbobenzyloxy L-Asp-L-Phe methyl ester
additional information
-
evaluation of an efficient method for the immobilization of thermolysin using sodium chloride salting-in and consecutive microwave irradiation, overview. 4.6% of the relative activity for the immobilized thermolysin is detected when the immobilization mixture contains no salts, including ZnCl2, CaCl2 or NaCl
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Morihara, K.; Tsuzuki, H.
Comparative study of various neutral proteinases from microorganisms: specificity with oligopeptides
Arch. Biochem. Biophys.
146
291-296
1971
Aspergillus oryzae, Bacillus thermoproteolyticus
brenda
Ohta, Y.; Ogura, Y.; Wada, A.
Thermostable protease from thermophilic bacteria. I. Thermostability, physiocochemical properties, and amino acid composition
J. Biol. Chem.
241
5919-5925
1966
Bacillus thermoproteolyticus
brenda
Nurul Alam, M.; Tadasa, K.; Kayahara, H.
Kinetic behavior of activation of thermolysin by normal alcohols
Biotechnol. Lett.
18
45-50
1996
Bacillus thermoproteolyticus
-
brenda
Inagaki, T.; Tadasa, K.; Kayahara, H.
Modification effects of organic solvents on microenvironment of the enzyme in thermolysin-catalyzed peptide synthesis of N-(benzyloxycarbonyl)-L-phenylalanyl-L-phenylalanine methyl ester
Biosci. Biotechnol. Biochem.
58
1439-1442
1994
Bacillus thermoproteolyticus
-
brenda
Marcotte, P.A.; Henkin, J.
Characterization of the activation of pro-urokinase by thermolysin
Biochim. Biophys. Acta
1161
105-112
1993
Bacillus thermoproteolyticus
brenda
Zamai, M.; Fassina, G.
Mobile phase effects in the high-performance affinity purification of thermolysin
J. Chromatogr.
549
195-205
1991
Bacillus thermoproteolyticus
-
brenda
Yang, J.J.; van Wart, H.E.
Kinetics of hydrolysis of dansyl peptide substrates by thermolysin: analysis of fluorescence changes and determination of steady-state kinetic parameters
Biochemistry
33
6508-6515
1994
Bacillus thermoproteolyticus
brenda
Gettins, P.
Thermolysin-inhibitor complexes examined by 31P and 113Cd NMR spectroscopy
J. Biol. Chem.
263
10208-10211
1988
Bacillus thermoproteolyticus
brenda
Grobelny, D.; Poncz, L.; Galardy, R.E.
Inhibition of human skin fibroblast collagenase, thermolysin, and Pseudomonas aeruginosa elastase by peptide hydroxamic acids
Biochemistry
31
7152-7154
1992
Bacillus thermoproteolyticus
brenda
Christianson, D.W.; Lipscomb, W.N.
Comparison of carboxypeptidase A and thermolysin: inhibition by phosphonamidates
J. Am. Chem. Soc.
110
5560-5565
1988
Bacillus thermoproteolyticus
-
brenda
Kitagishi, K.; Hiromi, K.
Binding between thermolysin and its specific inhibitor, N-phosphoryl-L-leucyl-L-tryptophan (PLT)
J. Biochem.
99
191-197
1986
Bacillus thermoproteolyticus
brenda
Kitagishi, K.; Hiromi, K.
Binding between thermolysin and its specific inhibitor, phosphoramidon
J. Biochem.
95
529-534
1984
Bacillus thermoproteolyticus
brenda
Maycock, A.L.; DeSousa, D.M.; Payne, L.G.; ten Broeke, J.; Wu, M.T.; Patchett, A.A.
Inhibition of thermolysin by N-carboxymethyl dipeptides
Biochem. Biophys. Res. Commun.
102
963-969
1981
Bacillus thermoproteolyticus
brenda
Gray, R.D.; Pierce, W.M.; Harrod, J.W.; Rademacher, J.M.
Inhibition of thermolysin by bifunctional N-carboxyalkyl dipeptides
Arch. Biochem. Biophys.
256
692-698
1987
Bacillus thermoproteolyticus
brenda
Durrant, I.; Beynon, R.J.; Rodgers, P.B.
The effect of inhibitors on thermolysin-catalyzed peptide bond synthesis
Biochem. Soc. Trans.
14
143
1986
Bacillus thermoproteolyticus
-
brenda
Nakanishi, K.; Kimura, Y.; Matsuno, R.
Kinetics and equilibrium of enzymatic synthesis of peptides in aqueous/organic biphasic systems. Thermolysin-catalyzed synthesis of N-(benzyloxycarbonyl)-L-aspartyl-L-phenylalanine methyl ester [published erratum appears in Eur J Biochem 1987 Sep 15;167(3):601]
Eur. J. Biochem.
161
541-549
1986
Bacillus thermoproteolyticus
brenda
Feder, J.; Brougham, L.R.; Wildi, B.S.
Inhibition of thermolysin by dipeptides
Biochemistry
13
1186-1189
1974
Bacillus thermoproteolyticus
brenda
Titani, K.; Hermodson, M.A.; Ericsson, L.H.; Walsh, K.A.; Neurath, H.
Amino acid sequence of thermolysin. Isolation and characterization of the fragments obtained by cleavage with cyanogen bromide
Biochemistry
11
2427-2435
1972
Bacillus thermoproteolyticus
brenda
Nishino, N.; Powers, J.C.
Peptide hydroxamic acids as inhibitors of thermolysin
Biochemistry
17
2846-2850
1978
Bacillus thermoproteolyticus
brenda
Morgan, G.; Fruton, J.S.
Kinetics of the action of thermolysin on peptide substrates
Biochemistry
17
3562-3568
1978
Bacillus thermoproteolyticus
brenda
Rasnick, D.; Powers, J.C.
Active site directed irreversible inhibition of thermolysin
Biochemistry
17
4363-4369
1978
Bacillus thermoproteolyticus
brenda
Kam, C.M.; Nishino, N.; Powers, J.C.
Inhibition of thermolysin and carboxypeptidase A by phosphoramidates
Biochemistry
18
3032-3038
1979
Bacillus thermoproteolyticus
brenda
Nishino, N.; Powers, J.C.
Design of potent reversible inhibitors for thermolysin. Peptides containing zinc coordinating ligands and their use in affinity chromatography
Biochemistry
18
4340-4347
1979
Bacillus thermoproteolyticus
brenda
Holmes, M.A.; Matthews, B.W.
Binding of hydroxamic acid inhibitors to crystalline thermolysin suggests a pentacoordinate zinc intermediate in catalysis
Biochemistry
20
6912-6920
1981
Bacillus thermoproteolyticus
brenda
Weaver, L.H.; Lester, W.R.; Matthews, B.W.
A crystallographic study of the complex of phosphoramidon with thermolysin. A model for the presumed catalytic transition state and for the binding of extended substances
J. Mol. Biol.
114
119-132
1977
Bacillus thermoproteolyticus
brenda
Kester, W.R.; Matthews, B.W.
Crystallographic study of the binding of dipeptide inhibitors to thermolysin: implications for the mechanism of catalysis
Biochemistry
16
2506-2516
1977
Bacillus thermoproteolyticus
brenda
Tajima, M.; Urabe, I.; Yutani, K.; Okada, H.
Role of calcium ions in the thermostability of thermolysin and Bacillus subtilis var. amylosacchariticus neutral protease
Eur. J. Biochem.
64
243-247
1976
Bacillus thermoproteolyticus
brenda
Matthews, B.W.; Colman, P.M.; Jansonius, J.N.; Titani, K.; Walsh, K.A.; Neurath, H.
Structure of thermolysin
Nat. New Biol.
238
41-43
1972
Bacillus thermoproteolyticus
brenda
Hersh, L.B.; Morihara, K.
Comparison of the subsite specificity of the mammalian neutral endopeptidase 24.11 (enkephalinase) to the bacterial neutral endopeptidase thermolysin
J. Biol. Chem.
261
6433-6437
1986
Bacillus thermoproteolyticus
brenda
Fujiwara, K.; Tsuru, D.
Affinity chromatography of neutral and alkaline proteases from Bacillus subtilis and of thermolysin
J. Biochem.
76
883-886
1974
Bacillus thermoproteolyticus
brenda
Colman.P.M.; Jansonius, J.N.; Matthews, B.M.
The structure of thermolysin: an electron density map at 2-3 A resolution
J. Mol. Biol.
70
701-724
1972
Bacillus thermoproteolyticus
brenda
Morihara, K.; Tsuzuki, H.; Oka, T.
Comparison of the specificities of various neutral proteinases from microorganisms
Arch. Biochem. Biophys.
123
572-588
1968
Aspergillus oryzae, Bacillus thermoproteolyticus
brenda
Holland, D.R.; Tronrud, D.E.; Pley, H.W.; Flaherty, K.M.; Stark, W.; Jansonius, J.N.; McKay, D.B.; Matthews, B.W.
Structural comparison suggests that thermolysin and related neutral proteases undergo hinge-bending motion during catalysis
Biochemistry
31
11310-11316
1992
Bacillus thermoproteolyticus
brenda
Gaucher, J.F.; Selkti, M.; Prange, T.; Tomas, A.
The 2.2 A resolution structure of thermolysin (TLN) crystallized in the presence of potassium thiocyanate
Acta Crystallogr. Sect. D
58
2198-2200
2002
Bacillus thermoproteolyticus (P00800), Bacillus thermoproteolyticus
brenda
Marie-Claire, C.; Ruffet, E.; Antonczak, S.; Beaumont, A.; O'Donohue, M.; Roques, B.P.; Fournie-Zaluski, M.C.
Evidence by site-directed mutagenesis that arginine 203 of thermolysin and arginine 717 of neprilysin (neutral endopeptidase) play equivalent critical roles in substrate hydrolysis and inhibitor binding
Biochemistry
36
13938-13945
1997
Bacillus thermoproteolyticus, Bacillus thermoproteolyticus Rokko
brenda
Gaucher, J.F.; Selkti, M.; Tiraboschi, G.; Prange, T.; Roques, B.P.; Tomas, A.; Fournie-Zaluski, M.C.
Crystal structures of alpha-mercaptoacyldipeptides in the thermolysin active site: structural parameters for a Zn monodentation or bidentation in metalloendopeptidases
Biochemistry
38
12569-12576
1999
Bacillus thermoproteolyticus (P00800)
brenda
Ligne, T.; Pauthe, E.; Monti, J.P.; Gacel, G.; Larreta-Garde, V.
Additional data about thermolysin specificity in buffer- and glycerol-containing media
Biochim. Biophys. Acta
1337
143-148
1997
Bacillus thermoproteolyticus, Bacillus thermoproteolyticus Rokko
brenda
Kudryashova, E.V.; Mozhaev, V.V.; Balny, C.
Catalytic activity of thermolysin under extremes of pressure and temperature: modulation by metal ions
Biochim. Biophys. Acta
1386
199-210
1998
Bacillus thermoproteolyticus, Bacillus thermoproteolyticus Rokko
brenda
Takeuchi, T.; Bottcher, A.; Quezada, C.M.; Meade, T.J.; Gray, H.B.
Inhibition of thermolysin and human alpha-thrombin by cobalt(III) Schiff base complexes
Bioorg. Med. Chem.
7
815-819
1999
Bacillus thermoproteolyticus
brenda
Murakami, Y.; Chiba, K.; Oda, T.; Hirata, A.
Novel kinetic analysis of enzymatic dipeptide synthesis: effect of pH and substrates on thermolysin catalysis
Biotechnol. Bioeng.
74
406-415
2001
Bacillus thermoproteolyticus
brenda
Marie-Claire, C.; Ruffet, E.; Tiraboschi, G.; Fournie-Zaluski, M.C.
Differences in transition state stabilization between thermolysin (EC 3.4.24.27) and neprilysin (EC 3.4.24.11)
FEBS Lett.
438
215-219
1998
Bacillus thermoproteolyticus
brenda
Inouye, K.; Lee, S.B.; Nambu, K.; Tonomura, B.
Effects of pH, temperature, and alcohols on the remarkable activation of thermolysin by salts
J. Biochem.
122
358-364
1997
Bacillus thermoproteolyticus
brenda
Kuzuya, K.; Inouye, K.
Effects of cobalt-substitution of the active zinc ion in thermolysin on its activity and active-site microenvironment
J. Biochem.
130
783-788
2001
Bacillus thermoproteolyticus
brenda
Muta, Y.; Inouye, K.
Inhibitory effects of alcohols on thermolysin activity as examined using a fluorescent substrate
J. Biochem.
132
945-951
2002
Bacillus thermoproteolyticus
brenda
Baltora-Rosset, S.; Aboubeker, A.; Dupradeau, F.Y.; Pauthe, E.; Gacel, G.A.; Larreta-Garde, V.; Monti, J.P.
Structural studies by 1H NMR and molecular modeling of peptide substrates of thermolysin in relation with its proteasic activity in water and glycerol
J. Biomol. Struct. Dyn.
16
1061-1074
1999
Bacillus thermoproteolyticus, Bacillus thermoproteolyticus Rokko
brenda
English, A.C.; Done, S.H.; Caves, L.S.; Groom, C.R.; Hubbard, R.E.
Locating interaction sites on proteins: the crystal structure of thermolysin soaked in 2% to 100% isopropanol
Proteins
37
628-640
1999
Bacillus thermoproteolyticus
brenda
Kamo, M.; Inouye, K.; Nagata, K.; Tanokura, M.
Preliminary X-ray crystallographic analysis of thermolysin in the presence of 4 M NaCl
Acta crystallogr. Sect. D
61
710-712
2005
Bacillus thermoproteolyticus
brenda
Oneda, H.; Muta, Y.; Inouye, K.
Substrate-dependent activation of thermolysin by salt
Biosci. Biotechnol. Biochem.
68
1811-1813
2004
Bacillus thermoproteolyticus
brenda
Kawasaki, T.; Hoshino, Y.; Ishizu, Y.; Mizushiro, Y.; Okahata, Y.
Control of hydrolysis and condensation activities of thermolysin by ultrasound irradiation
Chem. Lett.
34
1602-1603
2005
Bacillus thermoproteolyticus
-
brenda
Oda, K.; Takahashi, T.; Takada, K.; Tsunemi, M.; Ng, K.K.; Hiraga, K.; Harada, S.
Exploring the subsite-structure of vimelysin and thermolysin using FRETS-libraries
FEBS Lett.
579
5013-5018
2005
Bacillus thermoproteolyticus
brenda
Lapointe, J.; Molle, D.; Gauthier, S.F.; Pouliot, Y.
Effect of calcium on thermolysin hydrolysis of ?-casein tryptic peptides
Int. Dairy J.
14
185-193
2004
Bacillus thermoproteolyticus
brenda
NNegue, M.; Miclo, L.; Girardet, J.; Campagna, S.; Molle, D.; Gaillard, J.
Proteolysis of bovine ?-lactalbumin by thermolysin during thermal denaturation
Int. Dairy J.
16
1157-1167
2006
Bacillus thermoproteolyticus
brenda
Matsumiya, Y.; Nishikawa, K.; Aoshima, H.; Inouye, K.; Kubo, M.
Analysis of autodegradation sites of thermolysin and enhancement of its thermostability by modifying Leu155 at an autodegradation site
J. Biochem.
135
547-553
2004
Bacillus thermoproteolyticus
brenda
Kusano, M.; Yasukawa, K.; Hashida, Y.; Inouye, K.
Engineering of the pH-dependence of thermolysin activity as examined by site-directed mutagenesis of Asn112 located at the active site of thermolysin
J. Biochem.
139
1017-1023
2006
Bacillus thermoproteolyticus (P00800)
brenda
Hernandez-Ledesma, B.; Ramos, M.; Recio, I.; Amigo, L.
Effect of beta-lactoglobulin hydrolysis with thermolysin under denaturing temperatures on the release of bioactive peptides
J. Chromatogr. A
1116
31-37
2006
Bacillus thermoproteolyticus
brenda
Matsumiya, Y.; Nishikawa, K.; Inouye, K.; Kubo, M.
Mutational effect for stability in a conserved region of thermolysin
Lett. Appl. Microbiol.
40
329-334
2005
Bacillus thermoproteolyticus
brenda
Inouye, K.; Minoda, M.; Takita, T.; Sakurama, H.; Hashida, Y.; Kusano, M.; Yasukawa, K.
Extracellular production of recombinant thermolysin expressed in Escherichia coli, and its purification and enzymatic characterization
Protein Expr. Purif.
46
248-255
2006
Bacillus thermoproteolyticus
brenda
Pedersen, N.R.; Kristensen, J.B.; Bauw, G.; Ravoo, B.J.; Darcy, R.; Larsen, K.L.; Pedersen, L.H.
Thermolysin catalyzes the synthesis of cyclodextrin esters in DMSO
Tetrahedron
16
615-622
2005
Bacillus thermoproteolyticus
-
brenda
Perez-Victoria, I.; Morales, J.C.
Regioselectivity in acylation of oligosaccharides catalyzed by the metalloprotease thermolysin
Tetrahedron
62
2361-2369
2006
Bacillus thermoproteolyticus
-
brenda
Yasukawa, K.; Inouye, K.
Improving the activity and stability of thermolysin by site-directed mutagenesis
Biochim. Biophys. Acta
1774
1281-1288
2007
Bacillus thermoproteolyticus
brenda
Takita, T.; Aono, T.; Sakurama, H.; Itoh, T.; Wada, T.; Minoda, M.; Yasukawa, K.; Inouye, K.
Effects of introducing negative charges into the molecular surface of thermolysin by site-directed mutagenesis on its activity and stability
Biochim. Biophys. Acta
1784
481-488
2008
Bacillus thermoproteolyticus (P00800)
brenda
Inouye, K.; Nakamura, K.; Kusano, M.; Yasukawa, K.
Improvement in performance of affinity gels containing Gly-D-Phe as a ligand to thermolysin due to increasing the spacer chain length
Biosci. Biotechnol. Biochem.
71
2083-2086
2007
Bacillus thermoproteolyticus
brenda
Inouye, K.; Kusano, M.; Hashida, Y.; Minoda, M.; Yasukawa, K.
Engineering, expression, purification, and production of recombinant thermolysin
Biotechnol. Annu. Rev.
13
43-64
2007
Geobacillus stearothermophilus, Bacillus thermoproteolyticus, Geobacillus stearothermophilus MK232
brenda
Tatsumi, C.; Hashida, Y.; Yasukawa, K.; Inouye, K.
Effects of site-directed mutagenesis of the surface residues Gln128 and Gln225 of thermolysin on its catalytic activity
J. Biochem.
141
835-842
2007
Bacillus thermoproteolyticus
brenda
Hashida, Y.; Inouye, K.
Kinetic analysis of the activation-and-inhibition dual effects of cobalt ion on thermolysin activity
J. Biochem.
141
843-853
2007
Bacillus thermoproteolyticus
brenda
Hashida, Y.; Inouye, K.
Molecular mechanism of the inhibitory effect of cobalt ion on thermolysin activity and the suppressive effect of calcium ion on the cobalt ion-dependent inactivation of thermolysin
J. Biochem.
141
879-888
2007
Bacillus thermoproteolyticus
brenda
Gokhale, N.H.; Bradford, S.; Cowan, J.A.
Stimulation and oxidative catalytic inactivation of thermolysin by copper.Cys-Gly-His-Lys
J. Biol. Inorg. Chem.
12
981-987
2007
Bacillus thermoproteolyticus
brenda
Pazhang, M.; Khajeh, K.; Ranjbar, B.; Hosseinkhani, S.
Effects of water-miscible solvents and polyhydroxy compounds on the structure and enzymatic activity of thermolysin
J. Biotechnol.
127
45-53
2006
Bacillus thermoproteolyticus
brenda
Blumberger, J.; Lamoureux, G.; Klein, M.L.
Peptide hydrolysis in thermolysin: ab initio QM/MM investigation of the Glu143-assisted water addition mechanism
J. Chem. Theory Comput.
3
1837-1850
2007
Bacillus thermoproteolyticus
brenda
Hu, Z.; Jiang, J.
Molecular dynamics simulations for water and ions in protein crystals
Langmuir
24
4215-4223
2008
Bacillus thermoproteolyticus
brenda
Owen, J.P.; Maddison, B.C.; Whitelam, G.C.; Gough, K.C.
Use of thermolysin in the diagnosis of prion diseases
Mol. Biotechnol.
35
161-170
2007
Bacillus thermoproteolyticus
brenda
Yasukawa, K.; Kusano, M.; Inouye, K.
A new method for the extracellular production of recombinant thermolysin by co-expressing the mature sequence and pro-sequence in Escherichia coli
Protein Eng. Des. Sel.
20
375-383
2007
Bacillus thermoproteolyticus
brenda
Yasukawa, K.; Kusano, M.; Nakamura, K.; Inouye, K.
Characterization of Gly-D-Phe, Gly-L-Leu, and D-Phe as affinity ligands to thermolysin
Protein Expr. Purif.
46
332-336
2006
Bacillus thermoproteolyticus
brenda
Cronier, S.; Gros, N.; Tattum, M.H.; Jackson, G.S.; Clarke, A.R.; Collinge, J.; Wadsworth, J.D.
Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin
Biochem. J.
416
297-305
2008
Bacillus thermoproteolyticus (P00800)
brenda
Liu, Y.H.; Konermann, L.
Conformational dynamics of free and catalytically active thermolysin are indistinguishable by hydrogen/deuterium exchange mass spectrometry
Biochemistry
47
6342-6351
2008
Bacillus thermoproteolyticus
brenda
Kusano, M.; Yasukawa, K.; Inouye, K.
Insights into the catalytic roles of the polypeptide regions in the active site of thermolysin and generation of the thermolysin variants with high activity and stability
J. Biochem.
145
103-113
2009
Bacillus thermoproteolyticus
brenda
Khan, M.T.; Fuskevag, O.M.; Sylte, I.
Discovery of potent thermolysin inhibitors using structure based virtual screening and binding assays
J. Med. Chem.
52
48-61
2009
Bacillus thermoproteolyticus
brenda
Dong, M.; Liu, H.
Origins of the different metal preferences of Escherichia coli peptide deformylase and Bacillus thermoproteolyticus thermolysin: a comparative quantum mechanical/molecular mechanical study
J. Phys. Chem. B
112
10280-10290
2008
Bacillus thermoproteolyticus (P00800), Bacillus thermoproteolyticus
brenda
Marguerre, A.K.; Kraemer, R.
Lanthanide-based fluorogenic peptide substrate for the highly sensitive detection of thermolysin
Bioorg. Med. Chem. Lett.
19
5757-5759
2009
Bacillus thermoproteolyticus
brenda
Khan, M.T.; Khan, R.; Wuxiuer, Y.; Arfan, M.; Ahmed, M.; Sylte, I.
Identification of novel quinazolin-4(3H)-ones as inhibitors of thermolysin, the prototype of the M4 family of proteinases
Bioorg. Med. Chem.
18
4317-4327
2010
Bacillus thermoproteolyticus
brenda
Liu, Z.; Zhang, P.; Zhou, Y.; Qin, H.; Shen, T.
Culture of human intestinal epithelial cell using the dissociating enzyme thermolysin and endothelin-3
Braz. J. Med. Biol. Res.
43
451-459
2010
Bacillus thermoproteolyticus
brenda
Adekoya, O.A.; Sylte, I.
The thermolysin family (M4) of enzymes: therapeutic and biotechnological potential
Chem. Biol. Drug Des.
73
7-16
2009
Bacillus cereus, Bacillus thermoproteolyticus
brenda
Englert, L.; Silber, K.; Steuber, H.; Brass, S.; Over, B.; Gerber, H.D.; Heine, A.; Diederich, W.E.; Klebe, G.
Fragment-based lead discovery: screening and optimizing fragments for thermolysin inhibition
ChemMedChem
5
930-940
2010
Bacillus thermoproteolyticus (P00800)
brenda
Asaoka, K.; Yasukawa, K.; Inouye, K.
Coagulation of soy proteins induced by thermolysin and comparison of the coagulation reaction with that induced by subtilisin Carlsberg
Enzyme Microb. Technol.
44
229-234
2009
Bacillus thermoproteolyticus
-
brenda
Kusano, M.; Yasukawa, K.; Inouye, K.
Synthesis of N-carbobenzoxy-L-aspartyl-L-phenylalanine methyl ester catalyzed by thermolysin variants with improved activity
Enzyme Microb. Technol.
46
320-325
2010
Bacillus thermoproteolyticus
-
brenda
Kusano, M.; Yasukawa, K.; Inouye, K.
Effects of the mutational combinations on the activity and stability of thermolysin
J. Biotechnol.
147
7-16
2010
Bacillus thermoproteolyticus
brenda
Hu, Z.; Jiang, J.
Chiral separation of racemic phenylglycines in thermolysin crystal: a molecular simulation study
J. Phys. Chem. B
113
15851-15857
2009
Bacillus thermoproteolyticus
brenda
Ceruso, M.; Howe, N.; Malthouse, J.P.
Mechanism of the binding of Z-L-tryptophan and Z-L-phenylalanine to thermolysin and stromelysin-1 in aqueous solutions
Biochim. Biophys. Acta
1824
303-310
2012
Bacillus sp. (in: Bacteria), Bacillus thermoproteolyticus
brenda
Menach, E.; Yasukawa, K.; Inouye, K.
Effects of site-directed mutagenesis of the loop residue of the N-terminal domain Gly117 of thermolysin on its catalytic activity
Biosci. Biotechnol. Biochem.
74
2457-2462
2010
Bacillus thermoproteolyticus
brenda
Birrane, G.; Bhyravbhatla, B.; Navia, M.
Synthesis of aspartame by thermolysin: an x-ray structural study
ACS Med. Chem. Lett.
5
706-710
2014
Bacillus thermoproteolyticus (P00800)
brenda
Chen, F.; Zhang, F.; Du, F.; Wang, A.; Gao, W.; Wang, Q.; Yin, X.; Xie, T.
A novel and efficient method for the immobilization of thermolysin using sodium chloride salting-in and consecutive microwave irradiation
Biores. Technol.
115
158-163
2012
Bacillus thermoproteolyticus, Bacillus thermoproteolyticus Rokko
brenda
Sato, Y.; Toyoda, T.; Shimizu-Ibuka, A.; Tamura, T.; Kobayashi-Hattori, K.; Nakamura, T.; Arai, S.; Mura, K.
Novel angiotensin I-converting enzyme inhibitory peptides found in a thermolysin-treated elastin with antihypertensive activity
Biosci. Biotechnol. Biochem.
76
1329-1333
2012
Bacillus thermoproteolyticus, Bacillus thermoproteolyticus Rokko
brenda
Adekoya, O.; Sjoeli, S.; Wuxiuer, Y.; Bilto, I.; Marques, S.; Santos, M.; Nuti, E.; Cercignani, G.; Rossello, A.; Winberg, J.; Sylte, I.
Inhibition of pseudolysin and thermolysin by hydroxamate-based MMP inhibitors
Eur. J. Med. Chem.
89
340-348
2014
Bacillus thermoproteolyticus
brenda
Hardre, H.; Kuhn, L.; Albrieux, C.; Jouhet, J.; Michaud, M.; Seigneurin-Berny, D.; Falconet, D.; Block, M.; Marechal, E.
The selective biotin tagging and thermolysin proteolysis of chloroplast outer envelope proteins reveals information on protein topology and association into complexes
Front. Plant Sci.
5
203
2014
Bacillus thermoproteolyticus
brenda
Guinane, C.; Kent, R.; Norberg, S.; O'Connor, P.; Cotter, P.; Hill, C.; Fitzgerald, G.; Stanton, C.; Ross, R.
Generation of the antimicrobial peptide caseicin A from casein by hydrolysis with thermolysin enzymes
Int. Dairy J.
49
1-7
2015
Bacillus thermoproteolyticus
-
brenda
Menach, E.; Yasukawa, K.; Inouye, K.
Effects of site-directed mutagenesis of Asn116 in the beta-hairpin of the N-terminal domain of thermolysin on its activity and stability
J. Biochem.
152
231-239
2012
Bacillus thermoproteolyticus (P00800)
brenda
Kim, C.; Lee, D.; Lee, C.; Ahn, I.
Dityrosine-based substrates for the selective and sensitive assay of thermolysin
J. Ind. Eng. Chem.
21
248-253
2015
Bacillus thermoproteolyticus
-
brenda
Osago, H.; Kobayashi-Miura, M.; Hamasaki, Y.; Hara, N.; Hiyoshi, M.; Tsuchiya, M.
Complete solubilization of cartilage using the heat-stable protease thermolysin for comprehensive GAG analysis
Anal. Biochem.
548
115-118
2018
Bacillus thermoproteolyticus
brenda
Rocha-Martin, J.; Fernandez-Lorente, G.; Guisan, J.
Sequential hydrolysis of commercial casein hydrolysate by immobilized trypsin and thermolysin to produce bioactive phosphopeptides
Biocatal. Biotransform.
36
159-171
2018
Bacillus thermoproteolyticus (P00800)
-
brenda